申请人:Andjelkovic Mirjana
公开号:US20090270505A1
公开(公告)日:2009-10-29
This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formula
wherein A
1
, A
2
, R
1
, m and n are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds inhibit carnitine palmitoyl transferase (CPT) activity, in particular CPT2 activity, and can be used as medicaments in methods for the treatment of diseases modulated by CPT2 inhibitors.
这项发明涉及新颖的4-二甲基氨基丁酸衍生物,其化学式如下:其中A1、A2、R1、m和n的定义如描述和索赔中所述,以及其药学上可接受的盐。这些化合物抑制肉碱棕榈酰基转移酶(CPT)活性,特别是CPT2活性,并可用作药物治疗受CPT2抑制剂调节的疾病的方法中的药物。